Jennifer Whipkey

Executive Director, Marketing-Regional Marketing Team at Stemline Oncology at Stemline Therapeutics

Jennifer Whipkey has extensive work experience in the pharmaceutical and healthcare industry. Jennifer is currently the Executive Director of Marketing for the Regional Marketing Team at Stemline Therapeutics. Prior to joining Stemline Therapeutics, Jennifer worked as a Senior Director of Marketing for the Regional Marketing Team at Gilead Sciences. Jennifer also served as the President of the DFW Chapter at the Healthcare Businesswomen's Association from 2016 to 2021.

Jennifer's previous roles include working at Regeneron Pharmaceuticals, Inc. as an Oncology Field Based Marketer, where they led commercial engagement efforts with Key Thought Leaders supporting the PD-1 (Libtayo) brand strategy. Jennifer also worked at Immunomedics as an Oncology Regional Marketer, championing commercial engagement efforts with key Thought Leaders supporting the brand strategy for metastatic triple negative breast cancer (mTNBC) market.

Their experience at Novartis included roles such as Regional Marketer for Aimovig, where they led the launch of the first migraine prevention immunotherapy to market, and they also worked as a Hematology Associate Director, focusing on key account strategies and resource development in the West Region.

Jennifer began their career at Coca-Cola Enterprises as an Account Manager before transitioning into the pharmaceutical and healthcare industry. Throughout their career, they have demonstrated expertise in marketing, sales, training, and strategic business development.

Jennifer Whipkey obtained a Master's of Organizational Management (MAOM) degree from the University of Phoenix, where they attended from 1997 to 1999. Prior to that, they pursued a degree in Business Administration with a focus on Marketing at National University, from 1990 to 1993.

Links

Previous companies

Gilead Sciences logo
Novartis logo

Timeline

  • Executive Director, Marketing-Regional Marketing Team at Stemline Oncology

    May, 2022 - present